Bill Baker

Prof. Bill Baker

Chemistry, University of South Florida, Tampa, Florida, USA
orcid

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 March 2007 in Natural Product Reports
Verified
Journal Article
Closed access
PDF file
MLMatthew D Lebar
Matthew D Lebar
JHJaime L. Heimbegner
Jaime L. Heimbegner
Bill BakerBill Baker
Bill Baker
Covering: up to the end of 2005 Marine natural products isolated from organisms collected from cold-water habitats are described. Emphasis is on bioactive compounds from tunicates, sponges, microbes, bryozoans, corals, algae, molluscs and echinoderms. Synthetic studies of several important classes of cold-water compounds are highlighted.

28 August 2012 in Future Medicinal Chemistry
Verified
Journal Article
Closed access
LCLaurent Calcul
Laurent Calcul
BZBo Zhang
Bo Zhang
UJUmesh K Jinwal
Umesh K Jinwal
CDChad A Dickey
Chad A Dickey
Bill BakerBill Baker
Bill Baker
Alzheimer’s disease (AD) is a neurodegenerative disorder and the most common form of dementia, affecting more than 5.4 million people in the USA. Although the cause of AD is not well understood, the cholinergic, amyloid and tau hypotheses were proposed to explain its development. Drug discovery for AD based on the cholinergic and amyloid theories have not been effective. In this article we summarize tau-based natural products as AD therapeutics from a variety of biological sources, including the anti-amyloid agent curcumin, isolated from turmeric, the microtubule stabilizer paclitaxel, from the Pacific Yew Taxus brevifolia, and the Streptomyces-derived Hsp90 inhibitor, geldanamycin. The overlooked approach of clearing tau aggregation will most likely be the next objective for AD drug discovery.

28 March 2012 in Marine Drugs
Verified
Journal Article
Open access
PDF file
JBJeremy Beau
Jeremy Beau
NMNida Mahid
Nida Mahid
WBWhittney N. Burda
Whittney N. Burda
LHLacey Harrington
Lacey Harrington
LSLindsey Shaw
Lindsey Shaw
Bill BakerBill Baker
Bill Baker
Recent genomic studies have demonstrated that fungi can possess gene clusters encoding for the production of previously unobserved secondary metabolites. Activation of these attenuated or silenced genes to obtain either improved titers of known compounds or new ones altogether has been a subject of considerable interest. In our efforts to discover new chemotypes that are effective against infectious diseases, including malaria and methicillin-resistant Staphylococcus aureus (MRSA), we have isolated a strain of marine fungus, Leucostoma persoonii, that produces bioactive cytosporones. Epigenetic modifiers employed to activate secondary metabolite genes resulted in enhanced production of known cytosporones B (1, 360%), C (2, 580%) and E (3, 890%), as well as the production of the previously undescribed cytosporone R (4). Cytosporone E was the most bioactive, displaying an IC90 of 13 µM toward Plasmodium falciparum, with A549 cytotoxicity IC90 of 437 µM, representing a 90% inhibition therapeutic index (TI90 = IC90 A459/IC90 P. falciparum) of 33. In addition, cytosporone E was active against MRSA with a minimal inhibitory concentration (MIC) of 72 µM and inhibition of MRSA biofilm at roughly half that value (minimum biofilm eradication counts, MBEC90, was found to be 39 µM).

21 March 2017 in Natural Product Reports
Verified
Journal Article
Closed access
PDF file
SSSylvia Soldatou
Sylvia Soldatou
Bill BakerBill Baker
Bill Baker
This is an update report on marine natural products isolated from cold-water organisms in the last decade, following the previous review that covered the literature up to 2005. Emphasis is on structural assignments and biological activity.

8 December 2010 in Journal of Natural Products
Verified
Journal Article
Closed access
JJJeffrey R. Jones
Jeffrey R. Jones
MLMatthew D Lebar
Matthew D Lebar
UJUmesh K. Jinwal
Umesh K. Jinwal
JAJose F. Abisambra
Jose F. Abisambra
JKJohn Koren
John Koren
CDChad A. Dickey
Chad A. Dickey

27 November 2007 in Journal of Natural Products
Verified
Journal Article
Closed access
YMYoshinari Miyata
Yoshinari Miyata
TDThushara Diyabalanage
Thushara Diyabalanage
CACharles Amsler
Charles Amsler
JMJames B. McClintock
James B. McClintock
FVFrederick A. Valeriote
Frederick A. Valeriote
Bill BakerBill Baker
Bill Baker